Zobrazeno 1 - 10
of 18
pro vyhledávání: '"John, Teerlink"'
Autor:
Antoni Bayes‐Genis, Alberto Aimo, Pardeep Jhund, Mark Richards, Rudolf A. de Boer, Henrike Arfsten, Iacopo Fabiani, Josep Lupón, Stefan D. Anker, Arantxa González, Vincenzo Castiglione, Marco Metra, Christian Mueller, Julio Núñez, Patrick Rossignol, Andrea Barison, Javed Butler, John Teerlink, Gerasimos Filippatos, Piotr Ponikowski, Giuseppe Vergaro, Faiez Zannad, Petar Seferovic, Giuseppe Rosano, Andrew J.S. Coats, Michele Emdin, James L. Januzzi
Publikováno v:
EUROPEAN JOURNAL OF HEART FAILURE
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
The approval of new heart failure (HF) therapies has slowed over the past two decades in part due to the high costs of conducting large randomized clinical trials that are needed to adequately power major clinical endpoint studies. Several biomarkers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99021eb90e4f684152345eb666a62796
https://pubmed.ncbi.nlm.nih.gov/36073112
https://pubmed.ncbi.nlm.nih.gov/36073112
Autor:
Wayne C. Levy, Paul Hauptman, Edward Gilbert, Peter Carson, John Teerlink, Eugene Chung, Robert Bourge, Marie-Elena Brett, John Henderson, Greg Ginn, Alan Miller
Publikováno v:
Journal of Cardiac Failure. 28:S91-S92
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7ac4684e02fd3c54c4d2f666a86d6b2
https://doi.org/10.1016/j.cardfail.2022.03.230
https://doi.org/10.1016/j.cardfail.2022.03.230
Autor:
Adriaan Voors, Christiane Angermann, John Teerlink, Sean Collins, Mikhail Kosiborod, Jan Biegus, Joao Pedro Ferreira, Michael Nassif, Mitchell Psotka, Jasper Tromp, Martina Bruekmann, Jon Blatchford, Afshin Salasali, Piotr Poniikowski
Publikováno v:
Heart & Lung. 55:172
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cdf6b2c7870bdb3601849c14fed31b8
https://doi.org/10.1016/j.hrtlng.2022.06.007
https://doi.org/10.1016/j.hrtlng.2022.06.007
Autor:
Giuseppe M C, Rosano, Larry A, Allen, Amr, Abdin, Joann, Lindenfeld, Eileen, O'Meara, Carolyn S P, Lam, Patrizio, Lancellotti, Gianluigi, Savarese, Stephen S, Gottlieb, John, Teerlink, Jan, Wintrich, Michael, Böhm
Publikováno v:
JACC. Heart failure. 9(11)
Medications with proven benefit in patients with heart failure with reduced ejection fraction are recommended, according to prospective large clinical trials, in the stable patient after careful up-titration in a strict sequential order. Although the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fcb3bbe43406df9c9705a0924c614f59
https://pubmed.ncbi.nlm.nih.gov/34627725
https://pubmed.ncbi.nlm.nih.gov/34627725
Autor:
Mona, Fiuzat, Naomi, Lowy, Norman, Stockbridge, Marco, Sbolli, Federica, Latta, JoAnn, Lindenfeld, Eldrin F, Lewis, William T, Abraham, John, Teerlink, Mary, Walsh, Paul, Heidenreich, Biykem, Bozkurt, Randall C, Starling, Scott, Solomon, G Michael, Felker, Javed, Butler, Clyde, Yancy, Lynne W, Stevenson, Christopher, O'Connor, Ellis, Unger, Robert, Temple, John, McMurray
Publikováno v:
JACC. Heart failure. 8(6)
Heart failure (HF) patients experience a high burden of symptoms and functional limitations, and morbidity and mortality remain high despite successful therapies. The majority of HF drugs in the United States are approved for reducing hospitalization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9088dc50a9ad961e5165a0d7fdabeea8
https://pubmed.ncbi.nlm.nih.gov/33004117
https://pubmed.ncbi.nlm.nih.gov/33004117
Autor:
Tor Biering-Sorensen, Alexander Papolos, John Teerlink, G. Michael Felker, John McMurray, Jason Legg, Fady Malik, Narimon Honarpour, Christopher Kurtz, Scott D. Solomon
Publikováno v:
Journal of the American College of Cardiology. 75:667
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::627b121c8c9d9fe5559845034c5abec1
https://doi.org/10.1016/s0735-1097(20)31294-8
https://doi.org/10.1016/s0735-1097(20)31294-8
Autor:
Marco Metra, Douwe Postmus, Beth Davison, Hans L. Hillege, Daniel Bloomfield, Piotr Ponikowski, John Teerlink, Michael Givertz, Gad Cotter, John Cleland, Howard Dittrich, Biniyam G. Demissei, Adriaan A. Voors, Licette C. Y. Liu, Christopher M. O'Connor
Publikováno v:
Journal of the American College of Cardiology, 67(13), 1440-1440. ELSEVIER SCIENCE INC
There is substantial variation in the etiology, clinical presentation and pathophysiology of patients hospitalized for acute heart failure (AHF) that may influence their natural history and response to therapy. We performed a post-hoc analysis of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fb3ff7d79e3299f5109012dbba968d4
https://research.rug.nl/en/publications/7fd6cbe2-5cbc-430f-a03e-0552090f2be7
https://research.rug.nl/en/publications/7fd6cbe2-5cbc-430f-a03e-0552090f2be7
Autor:
Sheeva Rajaei, Peter Groeneveld, John Teerlink, Mary Whooley, Mintu Turakhia, Ilana Richman, Anju Sahay, Vinay Kini, Paul A Heidenreich
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 8
Background: There is increasing interest in understanding the factors that influence the use of diagnostic imaging in heart failure in US health systems. However, there is limited data examining overall use and the impact of racial disparities in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e47b12d0e372dfe45231c56d2c93cf1b
https://doi.org/10.1161/circoutcomes.8.suppl_2.217
https://doi.org/10.1161/circoutcomes.8.suppl_2.217
Autor:
Sheeva Rajaei, Peter Groeneveld, John Teerlink, Mary Whooley, Mintu Turakhia, Ilana Richman, Anju Sahay, Vinay Kini, Paul Heidenreich
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 8
Background: The high use of cardiac imaging in the United States is increasingly scrutinized. We sought to determine differences in cardiac imaging between the Veterans Healthcare Administration (VA) and Medicare for veterans with heart failure (HF).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b23a474e4ad26bf2978bac13e46fdad
https://doi.org/10.1161/circoutcomes.8.suppl_2.315
https://doi.org/10.1161/circoutcomes.8.suppl_2.315
TAILORING THERAPY IN ACUTE HEART FAILURE: CAN BIOMARKERS DISTINGUISH RESPONDERS FROM NON-RESPONDERS?
Autor:
John Cleland, Marco Metra, Daniel Bloomfield, Douwe Postmus, Mattia A.E. Valente, Adriaan A. Voors, Michael Givertz, Beth Davison, Gad Cotter, Piotr Ponikowski, Dirk J. van Veldhuisen, John Teerlink, Peter van der Meer, Hans L. Hillege, Licette C. Y. Liu, Christopher M. O'Connor
Publikováno v:
Journal of the American College of Cardiology. 65(10)
Over the last 50 years, clinical trials of novel interventions for acute heart failure (AHF) have, with few exceptions, been neutral or shown harm. Biomarker profiles might identify subsets of patients that respond. We studied the effect of rolofylli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbfd91365bd93ef303dc9e311f704d04